(Boursier.com) — LNA Health fell 1.3% to 29.65 euros on Thursday, while the group posted operating revenue of 177 ME in the 1st quarter, up 6.4% compared to the same period of 2022, including 6.9% organic growth. The activity takes into account the sale and closure of two healthcare establishments in 2022, the effect of which will dissipate as the year progresses.
The group anticipates an acceleration in growth over the next few quarters… The tariff component should continue to strengthen to gradually compensate for the deceleration of the volume effect. This dynamic at work in all businesses, based on robust fundamentals, allows the group to renew its organic growth forecast of more than 6% for an annual Operating turnover of 725 ME.
Portzamparc speaks of a “solid start to the year”, in line with its expectations pending the presentation of the “Growing together” plan scheduled for July 3… The roadmap is confirmed with an acceleration of growth expected in the next quarters. The analyst’s annual scenario is validated (Operating ROC of 67 ME / Operating MOC of 9%). What to stay in the purchase on the file by aiming for a course of 40 euros…
©2023 Boursier.com